News ArchivesRead News
Stem cells will now take on Parkinson's
Thursday August 27, 2009
Sumitra Deb Roy
DNA - Taking the research of stem cell usage to treat Parkinson's disease a step further, doctors at Jaslok Hospital injected patient's own stem cells to his brain.
The hospital claimed it was the world's first clinical trial for Parkinson's disease (PD).
Fifty-five-year-old Bhawarlal Jain, who had great difficulty in walking and talking, was diagnosed with this brain degenerative disease six years ago.
"My hands became stiff and my movements got restricted. It gradually started affecting my daily activities," he said. He underwent the procedure on August 8 and doctors will monitor him for the next 18 months to conclude if transplanting stem cells can cure the Parkinson's disease.
In Jain's case, bone marrow was taken from his hip bone. "The stem cells were cultivated and processed for two-three weeks at Reliance Life Sciences and injected in the patient's brain," said Dr Paresh Doshi, head, department of stereotactic and functional neurosurgery at Jaslok Hospital.
"Neural transplant is the only procedure that can restore the normal functions like speech, motor activities," he said.
Doshi said that in advanced stages of PD, medicines stop having any affect after a point. Jain was injected the cells under local anaesthesia as the patient is required to be in senses.
"Also, the cells are from patient's own bone marrow so there are no chances of rejection," said Doshi. Chances of abnormal growth of cells are also ruled out as the mesenchymal cells stop growing after a point. The hospital will be performing 10 such cases and evaluate them over a period of three years.
Recent NewsOct 18 - Fighting Parkinson's disease through dance
Oct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show